✦ LIBER ✦

Phase II trial of vaginal cuff brachytherapy followed by chemotherapy in early stage endometrial cancer patients with high-intermediate risk factors

✍ Scribed by Landrum, Lisa M.; Nugent, Elizabeth K.; Zuna, Rosemary E.; Syzek, Elizabeth; Mannel, Robert S.; Moore, Kathleen N.; Walker, Joan L.; McMeekin, D. Scott

Book ID: 122762372
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 146 KB
Volume: 132
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2013.11.005

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adjuvant Vaginal Brachytherapy and Chemo

Adjuvant Vaginal Brachytherapy and Chemotherapy in the Management of High-Intermediate Risk Early-stage Endometrial Cancer: A Single Institutional Report

✍ Iglesias, A.J.; Wolfson, A.H.; Portelance, L.; Zhao, W.; Stine, J.; Yali, P.; Lu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 37 KB

1A randomized phase III trial of pelvic

1A randomized phase III trial of pelvic radiation therapy (PXRT) versus vaginal cuff brachytherapy followed by paclitaxel/carboplatin chemotherapy (VCB/C) in patients with high risk (HR), early stage endometrial cancer (EC): A Gynecologic Oncology Group trial

✍ McMeekin, D.S.; Filiaci, V.L.; Aghajanian, C.; Cho, J.; Kim, J.W.; DiSilvestro, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Phase II trial of neoadjuvant docetaxel

Phase II trial of neoadjuvant docetaxel and gefitinib followed by radical prostatectomy in patients with high-risk, locally advanced prostate cancer

✍ Jacqueline Vuky; Christopher Porter; Christina Isacson; Matthew Vaughan; Paul Ko 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB 👁 1 views

## Abstract ## BACKGROUND: Prostate cancer trials investigating neoadjuvant hormonal therapy, followed by surgery, have demonstrated that elimination of all tumor cells from the primary site is rare. The authors report a phase 2 trial assessing the efficacy and toxicity of docetaxel and gefitinib

A pilot trial of TAC (paclitaxel, doxoru

A pilot trial of TAC (paclitaxel, doxorubicin, and carboplatin) chemotherapy with filgastrim (r-metHuG-CSF) support followed by radiotherapy in patients with “high-risk” endometrial cancer

✍ Linda R. Duska; Ross Berkowitz; Ursula Matulonis; Michael Muto; Annekathryn Good 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 356 KB

Randomized phase III trial of pelvic rad

Randomized phase III trial of pelvic radiotherapy versus cisplatin-based combined chemotherapy in patients with intermediate- and high-risk endometrial cancer: A Japanese Gynecologic Oncology Group study

✍ Nobuyuki Susumu; Satoru Sagae; Yasuhiro Udagawa; Kenji Niwa; Hiroyuki Kuramoto; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 313 KB

A phase I/II trial of induction chemothe

A phase I/II trial of induction chemotherapy with carboplatin and gemcitabine followed by concurrent vinorelbine and paclitaxel with chest radiation in patients with stage III non-small cell lung cancer

✍ Argiris, A; Liptay, M; LaCombe, M; Marymont, M; Kies, M.S; Sundaresan, S; Master 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 133 KB